Melillo G - Search Results

1

Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α.

Shalova IN, Lim JY, Chittezhath M, Zinkernagel AS, Beasley F, Hernández-Jiménez E, Toledano V, Cubillos-Zapata C, Rapisarda A, Chen J, Duan K, Yang H, Poidinger M, Melillo G, Nizet V, Arnalich F, López-Collazo E, Biswas SK. Shalova IN, et al. Among authors: melillo g. Immunity. 2015 Mar 17;42(3):484-98. doi: 10.1016/j.immuni.2015.02.001. Epub 2015 Mar 3. Immunity. 2015. PMID: 25746953 Free article.

2

Targeting topoisomerase I to inhibit hypoxia inducible factor 1.

Rapisarda A, Shoemaker RH, Melillo G. Rapisarda A, et al. Among authors: melillo g. Cell Cycle. 2004 Feb;3(2):172-5. Cell Cycle. 2004. PMID: 14712084 Review.

3

Role of the VEGF/VEGFR axis in cancer biology and therapy.

Rapisarda A, Melillo G. Rapisarda A, et al. Among authors: melillo g. Adv Cancer Res. 2012;114:237-67. doi: 10.1016/B978-0-12-386503-8.00006-5. Adv Cancer Res. 2012. PMID: 22588059 Review.

4

Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads.

Rapisarda A, Shoemaker RH, Melillo G. Rapisarda A, et al. Among authors: melillo g. Cell Cycle. 2009 Dec 15;8(24):4040-3. doi: 10.4161/cc.8.24.10145. Epub 2009 Dec 21. Cell Cycle. 2009. PMID: 19923892

5

Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications.

Rapisarda A, Uranchimeg B, Sordet O, Pommier Y, Shoemaker RH, Melillo G. Rapisarda A, et al. Among authors: melillo g. Cancer Res. 2004 Feb 15;64(4):1475-82. doi: 10.1158/0008-5472.can-03-3139. Cancer Res. 2004. PMID: 14983893

6

Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies.

Rapisarda A, Melillo G. Rapisarda A, et al. Among authors: melillo g. Drug Resist Updat. 2009 Jun;12(3):74-80. doi: 10.1016/j.drup.2009.03.002. Epub 2009 Apr 25. Drug Resist Updat. 2009. PMID: 19394890 Free PMC article. Review.

7

Development of HIF-1 inhibitors for cancer therapy.

Onnis B, Rapisarda A, Melillo G. Onnis B, et al. Among authors: melillo g. J Cell Mol Med. 2009 Sep;13(9A):2780-6. doi: 10.1111/j.1582-4934.2009.00876.x. Epub 2009 Aug 8. J Cell Mol Med. 2009. PMID: 19674190 Free PMC article. Review.

8

Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia.

Rapisarda A, Melillo G. Rapisarda A, et al. Among authors: melillo g. Nat Rev Clin Oncol. 2012 Apr 24;9(7):378-90. doi: 10.1038/nrclinonc.2012.64. Nat Rev Clin Oncol. 2012. PMID: 22525710 Review.

9

UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.

Rapisarda A, Melillo G. Rapisarda A, et al. Among authors: melillo g. Oncogene. 2007 Oct 18;26(48):6875-84. doi: 10.1038/sj.onc.1210489. Epub 2007 May 14. Oncogene. 2007. PMID: 17496931

10

Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, Melillo G. Rapisarda A, et al. Among authors: melillo g. Cancer Res. 2002 Aug 1;62(15):4316-24. Cancer Res. 2002. PMID: 12154035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page